ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma

Cancer

Volumn 94, Issue 11, 2002, Pages 2855-2861

  Yang, Wentao ^a,b   Klos, Kristine ^a   Yang, Ying ^a   Smith, Terry L ^a   Shi, Daren ^b   Yu, Dihua ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b FUDAN UNIVERSITY   (China)

Author keywords

Breast carcinoma; VEGF A; VEGF C; VEGF D, ErbB2

Indexed keywords

TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D;

ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE NEU; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION;

ADULT; AGED; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NECK; RECEPTOR, ERBB-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 0036604183     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10553     Document Type: Article

References (35)

1. Tumor angiogenesis and metastases: Correlation in invasive breast carcinoma
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
4. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
5. Identification of a c-fos-induced gene that is related to the plateletderived growth factor/vascular endothelial growth factor family
6. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
7. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
8. Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis
9. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth
10. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
11. Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment
12. The expression of vascular endothelial growth factor correlates with mutant P53 and poor prognosis in human breast cancer
13. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
14. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
15. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
16. Prognostic importance of c-erbB-2 expression in breast cancer
17. Overexpression c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1 independent mechanisms
18. Overexpression of both p185cerbB2 and P170mdr-1 renders breast cancer cells superresistant to Taxol
19. Cdc2 kinase
20. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors
21. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1 alpha (HIF-1 alpha) synthesis: Novel mechanism for HIF-1 mediated vascular endothelial growth factor expression
22. Upregulation of VEGF in breast cancer cells by Heregulin-β1-activated P38 signaling pathway enhances endothelial cell migration
23. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer
24. Interpretation and quantification of immunostains
25. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma
26. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity
27. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
28. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas
29. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer
30. Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer
31. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies
32. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
33. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease
34. Overexpression of the c-erbB-2 gene enhanced intrinsic metastatic potential in human breast cancer cells without increasing their transformation abilities
35. Vascular endothelial growth factor family members are differentially regulated by c-erbB signaling in head and neck squamous carcinoma cells